| Product Name | LIH383 |
|---|---|
| Description | LIH383 is a highly selective agonist of the atypical chemokine receptor, ACKR3 (formerly known as CXCR7). Functionally, ACKR3 is a scavenger receptor for a wide variety of opioid peptides, especially enkephalins and dynorphins, reducing their availability for the classical opioid receptors. LIH383 competes directly with CXCL12-AF647 for ACKR3 binding at low nanomolar concentrations and is more potent in inducing β-arrestin recruitment to ACKR3 than the full-length chemokine ligands CXCL12 and CXCL11, with EC50 values of 1.2 nM and 2.2 nM respectively, and no effect on of any other opioid or chemokine receptor at concentrations up to 3 µM. LIH383 can restrain the negative regulatory function of ACKR3 on opioid peptides and potentiate their activity in rat brain. |
| Synonyms | ACKR3, CXCR7, LIH383, PN-220, PN220, atypical chemokine receptor, opioid, pain |
| Molecular Weight | 997.23 Da |
| Target | Chemokine receptors |
| Amino Acid Sequence | FGGFMRRK-NH2 |
| Form | Freeze dried solid |
| Purity | >95% by HPLC |
| Storage | Store desiccated, frozen and in the dark |
| Notes | Modifications: Amide at C terminal lysine |
| References |
Meyrath et al (2020) The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides. Nat. Commun. 11 3033 PMID: 32561830Szpakowska et al (2021) The natural analgesic conolidine targets the newly identified opioid scavenger ACKR3/CXCR7. Signal Transduct Target Ther. 6(1) 209 PMID: 34075018 Related areas All peptides >All chemokine receptor modulators >All pain research categories > |
| Supplier | Isca Biochemicals Limited |
All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.
